Clinical Trials Directory

Trials / Unknown

UnknownNCT04562077

Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome

Status
Unknown
Phase
Study type
Observational
Enrollment
25 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

role of surgery in treatment of recurrent brain glioma prognostic factors and outcome measures Role of surgery : In patients with Grade I gliomas, such as pilocytic astrocytomas, resection is potentially curative. For more diffuse invasive gliomas (Grade II or higher), initial management typically includes maximal safe resection when possible. Increasing evidence supports an association between extent of resection and prolonged progression-free and overall survival for patients with diffuse gliomas of all types and grades Many studies reported that more that 90%of patients with glioma showed recurrence at the orginal tumor location. Review the outcomes of re-operation in treatment of recurrent brain gliomas To determine the prognostic factors which can predict which patient would benefit from multiple surgery . Trail to Improve the outcome of these patients and decrease rate of complications

Conditions

Timeline

Start date
2020-10-01
Primary completion
2021-11-01
Completion
2021-11-01
First posted
2020-09-24
Last updated
2020-09-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04562077. Inclusion in this directory is not an endorsement.

Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome (NCT04562077) · Clinical Trials Directory